ASP2535
Type 1 Glycine transporter inhibitor
From Wikipedia, the free encyclopedia
ASP2535 is an inhibitor of the type 1 glycine transporter.[1] It could potentially be used in treatment of Alzheimer's disease and schizophrenia.
| Names | |
|---|---|
| IUPAC name
4-[3-(6-phenylpyridin-3-yl)-5-propan-2-yl-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C22H18N6O | |
| Molar mass | 382.427 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Potential uses
ASP2535 has been investigated for the treatment of Alzheimer's disease and schizophrenia, it is able to inhibit the memory deficit induced by scopolamine, an anticholinergic agent.[1]
